JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

JNJ

173.89

+0.19%↑

ABBV

198.28

+0.11%↑

AZN

74.06

+0.64%↑

NVS

118.5

+1.46%↑

ABT

131.52

-2.16%↓

Search

Elanco Animal Health Inc

Suletud

SektorTervishoid

17.11

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

16.89

Max

17.26

Põhinäitajad

By Trading Economics

Sissetulek

75M

67M

Müük

173M

1.2B

P/E

Sektori keskmine

18.76

34.393

Kasumimarginaal

5.616

Töötajad

9,000

EBITDA

86M

261M

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+5.64% upside

Dividendid

By Dow Jones

Järgmine tulemuste avaldamine

6. nov 2025

Turustatistika

By TradingEconomics

Turukapital

2.2B

7B

Eelmine avamishind

17.11

Eelmine sulgemishind

17.11

Uudiste sentiment

By Acuity

50%

50%

162 / 374 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Bullish Evidence

Elanco Animal Health Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

5. mai 2025, 11:29 UTC

Omandamised, ülevõtmised, äriostud

Elanco Sells Non-Core Asset to Blackstone for $295 Million

5. mai 2025, 11:14 UTC

Omandamised, ülevõtmised, äriostud

Elanco Sells Non-Core Asset to Blackstone for $295 Mln

5. mai 2025, 10:50 UTC

Omandamised, ülevõtmised, äriostud

Elanco Animal Health: Monetization of This Non-Core Asset Will Be Used to Accelerate Debt Reduction >ELAN

5. mai 2025, 10:49 UTC

Omandamised, ülevõtmised, äriostud

Elanco Sells Royalty and Milestone Rights for Lotilaner in Human Health to Blackstone for $295M

Võrdlus sarnastega

Hinnamuutus

Elanco Animal Health Inc Prognoos

Hinnasiht

By TipRanks

5.64% tõus

12 kuu keskmine prognoos

Keskmine 17.61 USD  5.64%

Kõrge 21 USD

Madal 15 USD

Põhineb 11 Wall Streeti analüütiku instrumendi Elanco Animal Health Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

11 ratings

8

Osta

3

Hoia

0

Müü

Tehniline skoor

By Trading Central

9.77 / N/AToetus ja vastupanu

Lühikene perspektiiv

Bullish Evidence

Keskpikk perspektiiv

Strong Bullish Evidence

Pikk perspektiiv

Weak Bullish Evidence

Sentiment

By Acuity

162 / 374 Pingereas Tervishoid

Uudiste sentiment

Neutral

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Elanco Animal Health Inc

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.